Home Cytoskeletal Signaling PKC inhibitor Darovasertib (LXS-196) For research use only.

Darovasertib (LXS-196)

Synonyms: IDE-196

Darovasertib (LXS-196, IDE-196) is a selective inhibitor of protein kinase C (PKC).

Darovasertib (LXS-196) Chemical Structure

Darovasertib (LXS-196) Chemical Structure

CAS: 1874276-76-2

Selleck's Darovasertib (LXS-196) has been cited by 4 publications

Purity & Quality Control

Batch: Purity: 99.83%
99.83

Other PKC Products

Related compound libraries

Choose Selective PKC Inhibitors

Biological Activity

Description Darovasertib (LXS-196, IDE-196) is a selective inhibitor of protein kinase C (PKC).
Targets
PKC [1]
In vitro
In vitro

LXS-196 (Darovasertib) is a highly specific PKC inhibitor that resulted in a concentration dependent inhibition of immunoprecipitated LRRK1 kinase activity, with an IC50 of ∼40 nM.
Cell Research Cell lines HEK293 cells
Concentrations ∼40 nM
Incubation Time 24 h
Method

Cells were treated with indicated concentration of the drug for 24 hour.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05907954 Recruiting Uveal Melanoma IDEAYA Biosciences July 3 2023 Phase 2
NCT03947385 Recruiting Metastatic Uveal Melanoma|Cutaneous Melanoma|Colorectal Cancer|Other Solid Tumors IDEAYA Biosciences June 28 2019 Phase 1|Phase 2
NCT02601378 Terminated Uveal Melanoma Novartis Pharmaceuticals|Novartis February 1 2016 Phase 1

Chemical lnformation & Solubility

Molecular Weight 472.47 Formula

C22H23F3N8O
CAS No. 1874276-76-2 SDF --
Smiles CC1(CCN(CC1)C2=C(N=CC=C2)NC(=O)C3=NC(=CN=C3N)C4=C(C=CC=N4)C(F)(F)F)N
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 94 mg/mL ( (198.95 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 47 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Darovasertib (LXS-196) | Darovasertib (LXS-196) supplier | purchase Darovasertib (LXS-196) | Darovasertib (LXS-196) cost | Darovasertib (LXS-196) manufacturer | order Darovasertib (LXS-196) | Darovasertib (LXS-196) distributor